Cargando…
Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness
Out-of-date or incomplete drug product labeling information may increase the risk of otherwise preventable adverse drug events. In recognition of these concerns, the United States Federal Drug Administration (FDA) requires drug product labels to include specific information. Unfortunately, several s...
Autores principales: | Boyce, Richard D, Horn, John R, Hassanzadeh, Oktie, Waard, Anita de, Schneider, Jodi, Luciano, Joanne S, Rastegar-Mojarad, Majid, Liakata, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698101/ https://www.ncbi.nlm.nih.gov/pubmed/23351881 http://dx.doi.org/10.1186/2041-1480-4-5 |
Ejemplares similares
-
Extending the “Web of Drug Identity” with Knowledge Extracted from United States Product Labels
por: Hassanzadeh, Oktie, et al.
Publicado: (2013) -
A Minimal Information Model for Potential Drug-Drug Interactions
por: Hochheiser, Harry, et al.
Publicado: (2021) -
Using Social Media Data to Identify Potential Candidates for Drug Repurposing: A Feasibility Study
por: Rastegar-Mojarad, Majid, et al.
Publicado: (2016) -
Assessing the Need of Discourse-Level Analysis in Identifying Evidence of Drug-Disease Relations in Scientific Literature
por: Rastegar-Mojarad, Majid, et al.
Publicado: (2015) -
Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey
por: Grizzle, Amy J, et al.
Publicado: (2019)